@FierceBiotech: After painful odyssey, Newron wins European OK for Parkinson's add-on. News | Follow @FierceBiotech
@JohnCFierce: Top story of the week: Exclusive: Pfizer is once again cutting back R&D staff in reorganization. Report | Follow @JohnCFierce
@DamianFierce: Hey so @FierceBiotech has a podcast now, and you can listen online and subscribe on iTunes. | Follow @DamianFierce
> San Francisco-based Illumina ($ILMN) reports that it has gained a $40 million commitment from Viking Global Investors to seed promising genomic startups that come out of its incubator. Release
> Atlanta-based Biota ($BOTA) has acquired Paris-based Anaconda Pharma and its lead antiviral for $8 million in cash, 3.5 million shares and up to $30 million in milestones. Anaconda Pharma's lead candidate is AP611074, an antiviral in development for condyloma, or anogenital warts, as well as the orphan disease recurrent respiratory papillomatosis. Release
> Amarin ($AMRN) is getting $15 million upfront and up to $154 million in milestones from Eddingpharm in exchange for development and commercialization rights to Vascepa in China. Release
Medical Device News
@FierceMedDev: ICYMI yesterday: In a medical first, three patients receive prosthetic hands in place of disabled ones. Article | Follow @FierceMedDev
@VarunSaxena2: Roche, BioMed X to jointly run diagnostics incubator in Germany. FierceDiagnostics story | Follow @VarunSaxena2
@EmilyWFierce: Cyberonics and Sorin to form U.K.-based company valued at $2.7B, aiming to boost hospital offerings. More from Bloomberg | Follow @EmilyWFierce
> Indian diagnostics company Thyrocare aims for $100M IPO. News
> FDA warns manufacturer of failing to report corrections to its device disinfection system. Report
Pharma News
@FiercePharma: Deal-weighing Pharmacyclics could draw $18B from J&J, Novartis: Bloomberg. Report | Follow @FiercePharma
@CarlyHFierce: ICYMI yesterday: Sidelined after tampering incident, GSK's alli is back on sale. Report | Follow @CarlyHFierce
> SC's top court backs Risperdal verdict against J&J, but cuts penalty to $136M. Story
> Sanofi's fight for Toujeo market share won't be easy, analysts say. Article
Vaccines News
> NewLink nets $20M Ebola milestone from Merck. Item
> Valeant touts PhII Provenge data following Dendreon buy. More
> Takeda places vaccines unit in Singapore to push for global growth. Article
> Combo of Bavarian Nordic's Prostvac and BMS' Yervoy yields promising PhI results. Story
> Pfizer trumpets positive Trumenba data ahead of ACIP vote. Report
Pharma Manufacturing News
> Impax reports significant jump in revenues as it gets plant problems behind it. Report
> Unused Forest Labs facility snapped up by Aprecia Pharmaceuticals. News
> New Jersey compounder indicted over unsanitary manufacturing. Story
> Bharat, Serum Institute ramp up production of their swine flu vaccines. Item
> Federal judge cuts off Maine's Internet drug supply chain. Article